Drug Research
Regeneron and Colorado Center for Personalized Medicine Announce Major...
Regeneron Pharmaceuticals, Inc. and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado Anschutz Medical Campus announced a large-scale research collaboration designed...
Press Releases
Sterling Pharma Solutions commence the production of potential COVID-19...
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19.
Sterling will be...
Press Releases
Abbott Earns Emergency Use Authorization for Another COVID-19 Antibody...
Abbott Laboratories has won Emergency Use Authorization for another COVID-19-related diagnostics test for antibodies. This morning, the company said the U.S. Food and Drug Administration...
Press Releases
Bellerophon Therapeutics Announces FDA Clears Initiation of Phase 3...
Bellerophon Therapeutics, Inc., a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious lung diseases, announced that the U.S. FDA accepted its Investigational...
Drug Research
Pfizer Outsources Branded Drug Production to Focus on Experimental...
Pfizer is taking on significant risk in a race to provide the world with a coronavirus vaccine. Pfizer is outsourcing the production of its own...
IT & Data Management
United Imaging delivered twelve mobile DR systems to support...
United Imaging, an innovation solution provider for advanced medical imaging and radiotherapy equipment, confirmed that the first batch of 12 mobile digital radiography (DR) systems...
Clinical Trials
Bioclinica Launches COVID-19 Clinical Endpoint Adjudication Solution
Bioclinica has introduced a specialized program for the adjudication of adverse events that could result from COVID-19 infection. Bioclinica's new program provides an out-of-the-box Clinical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.